As someone who has successfully used heroic doses of psilocybin to help me break free of crippling anxiety, I remain skeptical. This is just my personal experience. Psilocybin breaks down walls, in a sense. We all develop rigid patterns of thought, conscious and subconscious. When those rigid patterns are maladaptive, they create depression and/or anxiety. These patterns are virtually impossible to recognize, and even with an expert therapist helping us to identify them, they are just as virtually unshakeable. Imagine trying to understand what you look like in a world with no mirrors or reflective surfaces. Now imagine trying to correct your facial deficiencies with self-guided plastic surgery. That's the closest I can come to explaining it.
Psilocybin can shatter these ingrained patterns of thinking, creating brain plasticity, and allowing new patterns to become established. One must be careful about what is offered as a new "format" at this point; replacing one set of maladaptive behaviors with another can do much more harm than good.
This is to say that psilocybin is not a silver bullet. It may be (for some, or many, or even all--I only have my experience) a new opportunity for beginning. For me it was a key that opened a door to possibilities.
I say I am skeptical about the prospects for its long-term success because the vast majority of people are unlikely to put in the effort or make the hard choices required to find that new roadmap of thought. My suspicion is that much of the early reports of success are due to self-reported wishful thinking.
My 2 cents. I hope I am wrong, because it was a crucial piece of my puzzle. I'd like it to be available for others, even if it ultimately helps a minority.
I’m glad that you received some benefit. There is a need for options to treat many of the ills described by QTR. If even a minority benefit from psychedelics, they should be made available as part of a comprehensive treatment plan.
My experience eons ago was for a short term enhancement, and, as you say, if you're willing to put in the effort to keep the new mindset it can benefit you in the long run. Judging by how popular the new weight loss drugs are (the easy button, lol) I'm not so sure either that folks want to tackle their issues.
The Big Pharma lobby won’t go quietly. It’ll take a high-profile medical breakthrough and a strong advocate to push through this barrier. JFK’s presence is a help but he’s not going to spend political capital on it.
Perhaps not the best idea. Most studies have large methodological flaws, emphasizing positive effects while playing down the side effects, which include accelerated levels of panic and anxiety, cognitive dysfunction (especially working memory and attention) and major depressive episodes, with some considering self harm. Most studies have small sample size, statistical analyses inappropriate for the population distribution, few well chosen controls and follow up is only for a short period of time, with many in the population lost to that minimal follow (with no review of the why of this), Uses in any therapeutic setting require informed consent. Like many other pharmacological products - not anywhere close to being ready for prime time, wide spread use.
These substances are cheap to produce and many can't be patented. Even if mass adoption occurs, are the companies actually going to be making big enough profits to move the stock price much?
I suspect it's very similar to marijuana: Cheap to produce, yes, but the value comes from consistently getting what you expect, which is where branding comes in. Many users want to know what they're getting -- particularly in the era of fentanyl -- and they will pay for that.
I agree and in addition wonder what the product is for these companies? As I see it, we don’t need new psychedelics (we have many already in use for centuries). We need therapists or coaches who know how to manage the journey.
Also, based on my experience, in order for the changes acquired through the psychedelic experience to “stick”, a daily spiritual practice is necessary. This allows one to keep the awareness alive while navigating a path through the constantly changing circumstances of daily life. Ultimately to become the master of your mind rather than letting your mind master you. A coach or spiritual mentor can be very valuable.
I followed your lead here last year and started with small positions in Compass and Atai. Decided to double down in a significant way when Compass took a dive after what seemed like a misreading of the first Phase III trial report. The stock has roughly doubled since then, and I've been adding along the way. I sold the Atai and am focused just in Compass. My reading is that it's on track for FDA approval late in 2036.
It's now about one-third of my portfolio. Wish me/us luck!
good argument. but generally i stay out of healthcare. not that money can't be made there. i just don't believe it's about outcomes. AI yes. rockets yes. robots yes. if tesla was run like medicine in this country all we would have are a bunch of broken down expensive EVs.
another problem i see is the threat of a treatment that does NOT require you to take a pill every day until you die. same issue with cancer...we have an entrenched and profitable system that does not like challenges.
one of the ways i can see healthcare getting better in the US is if tech decides to get involved. they have the muscle. AI can do real outcomes based analysis of data. we currently have a medical system where much "science" is wrong, doctors are woefully behind, and it's making lots of money. why change?
i also don't know anyone that has been helped by psychedelics. not ketamine. not psilocibin. but that's a small sample. i also don't know anyone that was harmed by them.
actually just did remember something. 20 years ago i had an experience with MDMA that seemed to have a profound and lasting effect. i was about forgiving someone and it did stick.
I work in healthcare, in an urban area, and 50% of our patients admit to using or experimenting with THC, CBD oil, creams, lotions, edibles, hookah, shrooms a la carte or in combo with other well known substances. For any reason you can imagine - pain, anxiety, headaches, back pain, trouble sleeping, you name it. Vaping purses are the new Gucci on college campuses. If it's cheap, legal and available they will use it. This market hasn't been fully tapped, we are easily early stages. Agree. Would I try them tho? hell no, I work 50 hours a week.
As someone who has successfully used heroic doses of psilocybin to help me break free of crippling anxiety, I remain skeptical. This is just my personal experience. Psilocybin breaks down walls, in a sense. We all develop rigid patterns of thought, conscious and subconscious. When those rigid patterns are maladaptive, they create depression and/or anxiety. These patterns are virtually impossible to recognize, and even with an expert therapist helping us to identify them, they are just as virtually unshakeable. Imagine trying to understand what you look like in a world with no mirrors or reflective surfaces. Now imagine trying to correct your facial deficiencies with self-guided plastic surgery. That's the closest I can come to explaining it.
Psilocybin can shatter these ingrained patterns of thinking, creating brain plasticity, and allowing new patterns to become established. One must be careful about what is offered as a new "format" at this point; replacing one set of maladaptive behaviors with another can do much more harm than good.
This is to say that psilocybin is not a silver bullet. It may be (for some, or many, or even all--I only have my experience) a new opportunity for beginning. For me it was a key that opened a door to possibilities.
I say I am skeptical about the prospects for its long-term success because the vast majority of people are unlikely to put in the effort or make the hard choices required to find that new roadmap of thought. My suspicion is that much of the early reports of success are due to self-reported wishful thinking.
My 2 cents. I hope I am wrong, because it was a crucial piece of my puzzle. I'd like it to be available for others, even if it ultimately helps a minority.
Crucial piece of mine, as well...
I’m glad that you received some benefit. There is a need for options to treat many of the ills described by QTR. If even a minority benefit from psychedelics, they should be made available as part of a comprehensive treatment plan.
My experience eons ago was for a short term enhancement, and, as you say, if you're willing to put in the effort to keep the new mindset it can benefit you in the long run. Judging by how popular the new weight loss drugs are (the easy button, lol) I'm not so sure either that folks want to tackle their issues.
The Big Pharma lobby won’t go quietly. It’ll take a high-profile medical breakthrough and a strong advocate to push through this barrier. JFK’s presence is a help but he’s not going to spend political capital on it.
You could very well be right...
Perhaps not the best idea. Most studies have large methodological flaws, emphasizing positive effects while playing down the side effects, which include accelerated levels of panic and anxiety, cognitive dysfunction (especially working memory and attention) and major depressive episodes, with some considering self harm. Most studies have small sample size, statistical analyses inappropriate for the population distribution, few well chosen controls and follow up is only for a short period of time, with many in the population lost to that minimal follow (with no review of the why of this), Uses in any therapeutic setting require informed consent. Like many other pharmacological products - not anywhere close to being ready for prime time, wide spread use.
These substances are cheap to produce and many can't be patented. Even if mass adoption occurs, are the companies actually going to be making big enough profits to move the stock price much?
I suspect it's very similar to marijuana: Cheap to produce, yes, but the value comes from consistently getting what you expect, which is where branding comes in. Many users want to know what they're getting -- particularly in the era of fentanyl -- and they will pay for that.
I agree and in addition wonder what the product is for these companies? As I see it, we don’t need new psychedelics (we have many already in use for centuries). We need therapists or coaches who know how to manage the journey.
Also, based on my experience, in order for the changes acquired through the psychedelic experience to “stick”, a daily spiritual practice is necessary. This allows one to keep the awareness alive while navigating a path through the constantly changing circumstances of daily life. Ultimately to become the master of your mind rather than letting your mind master you. A coach or spiritual mentor can be very valuable.
I followed your lead here last year and started with small positions in Compass and Atai. Decided to double down in a significant way when Compass took a dive after what seemed like a misreading of the first Phase III trial report. The stock has roughly doubled since then, and I've been adding along the way. I sold the Atai and am focused just in Compass. My reading is that it's on track for FDA approval late in 2036.
It's now about one-third of my portfolio. Wish me/us luck!
Do they offer free samples to potential investors?
Trump to sign executive order on psychedelic drug used abroad to treat PTSD
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order
good argument. but generally i stay out of healthcare. not that money can't be made there. i just don't believe it's about outcomes. AI yes. rockets yes. robots yes. if tesla was run like medicine in this country all we would have are a bunch of broken down expensive EVs.
another problem i see is the threat of a treatment that does NOT require you to take a pill every day until you die. same issue with cancer...we have an entrenched and profitable system that does not like challenges.
one of the ways i can see healthcare getting better in the US is if tech decides to get involved. they have the muscle. AI can do real outcomes based analysis of data. we currently have a medical system where much "science" is wrong, doctors are woefully behind, and it's making lots of money. why change?
i also don't know anyone that has been helped by psychedelics. not ketamine. not psilocibin. but that's a small sample. i also don't know anyone that was harmed by them.
actually just did remember something. 20 years ago i had an experience with MDMA that seemed to have a profound and lasting effect. i was about forgiving someone and it did stick.
I work in healthcare, in an urban area, and 50% of our patients admit to using or experimenting with THC, CBD oil, creams, lotions, edibles, hookah, shrooms a la carte or in combo with other well known substances. For any reason you can imagine - pain, anxiety, headaches, back pain, trouble sleeping, you name it. Vaping purses are the new Gucci on college campuses. If it's cheap, legal and available they will use it. This market hasn't been fully tapped, we are easily early stages. Agree. Would I try them tho? hell no, I work 50 hours a week.
Market cap is $18.2 million. Swinging for the fences here. Your stocking picking has been phenomenal. I hope this one works out as well.